GRI
Income statement / Annual
Last year (2025), GRI Bio Inc's total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2025, GRI Bio Inc's net income was -$11.96 M.
See GRI Bio Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00 |
$22.54 M |
$0.00 |
$0.00 |
$0.00 |
$100.00 K |
$0.00 |
$0.00 |
| Cost of Revenue |
$4.00 K
|
$4.00 K
|
$57.00 K
|
$50.00 K
|
$73.00 K
|
$0.00
|
$735.00
|
$612.00
|
| Gross Profit |
-$4.00 K
|
-$4.00 K
|
-$57.00 K
|
-$50.00 K
|
-$73.00 K
|
$0.00
|
-$735.00
|
-$612.00
|
| Gross Profit Ratio |
0
|
-0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$6.82 M
|
$3.77 M
|
$3.23 M
|
$242.00 K
|
$5.19 M
|
$264.00 K
|
$1.88 M
|
$3.51 M
|
| General & Administrative Expenses |
$5.16 M
|
$4.41 M
|
$8.10 M
|
$2.00 M
|
$813.00 K
|
$1.20 M
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$62.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$5.16 M
|
$4.46 M
|
$8.10 M
|
$1.95 M
|
$4.00 M
|
$1.20 M
|
$1.27 M
|
$800.08 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$11.98 M
|
$8.23 M
|
$11.33 M
|
$2.19 M
|
$9.19 M
|
$1.46 M
|
$3.15 M
|
$4.31 M
|
| Cost And Expenses |
$11.98 M
|
$8.23 M
|
$11.39 M
|
$2.24 M
|
$9.26 M
|
$1.46 M
|
$3.15 M
|
$4.31 M
|
| Interest Income |
$21.00 K
|
$25.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.06 K
|
| Interest Expense |
$0.00
|
$0.00
|
$2.08 M
|
$653.00 K
|
$16.00 K
|
$34.00 K
|
$197.03 K
|
$0.00
|
| Depreciation & Amortization |
$4.00 K
|
$4.00 K
|
$57.00 K
|
$50.00 K
|
$73.00 K
|
$3.00 K
|
$735.00
|
$612.00
|
| EBITDA |
-$11.97 M |
-$8.20 M |
-$10.90 M |
-$2.51 M |
-$9.21 M |
-$1.46 M |
-$3.27 M |
-$4.31 M |
| EBITDA Ratio |
0
|
-0.36
|
0
|
0
|
0
|
-14.56
|
0
|
0
|
| Operating Income Ratio |
0
|
-0.37
|
0
|
0
|
0
|
-14.59
|
0
|
0
|
| Total Other Income/Expenses Net |
$21.00 K
|
$28.00 K
|
-$1.65 M
|
-$978.00 K
|
-$44.00 K
|
-$1.07 M
|
-$310.07 K
|
$1.06 K
|
| Income Before Tax |
-$11.96 M
|
-$8.21 M
|
-$13.04 M
|
-$3.22 M
|
-$9.30 M
|
-$2.53 M
|
-$3.46 M
|
-$4.31 M
|
| Income Before Tax Ratio |
0
|
-0.36
|
0
|
0
|
0
|
-25.31
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$11.96 M
|
-$8.21 M
|
-$13.04 M
|
-$3.22 M
|
-$9.30 M
|
-$2.53 M
|
-$3.46 M
|
-$4.31 M
|
| Net Income Ratio |
0
|
-0.36
|
0
|
0
|
0
|
-25.31
|
0
|
0
|
| EPS |
-121.8 |
-1545.88 |
-140450.24 |
-47135.48 |
-2827.16 |
-4693.64 |
-660968 |
-822780 |
| EPS Diluted |
-121.8 |
-1545.88 |
-140450.24 |
-47135.48 |
-2827.16 |
-4693.64 |
-660968 |
-822780 |
| Weighted Average Shares Out |
$98.16 K
|
$6.55 K
|
$1.58 K
|
$1.16 K
|
$11.60 K
|
$891.00
|
$891.00
|
$891.00
|
| Weighted Average Shares Out Diluted |
$98.16 K
|
$6.55 K
|
$1.58 K
|
$1.16 K
|
$11.60 K
|
$891.00
|
$891.00
|
$891.00
|
| Link |
|
|
|
|
|
|
|
|
